For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Congress gets into the PBM business
In the recently passed appropriations bill, Congress enacted several Pharmacy Benefit Manager (PBM) reforms it has been contemplating for years. On the surface, these…
Op-Eds
Reform Obamacare, Don’t Just Extend It
Obamacare must be reformed, not just extended, as the House recently voted to do. Intended as a program to help people gain insurance coverage, it…
Freedom Works Radio
Jeremy Nighohossian, Competitive Enterprise Institute “Trump Healthcare Plan a Mixed Bag”: Freedom Works Radio Show
Freedom Works Radio show interviews CEI’s expert on healthcare Listen to Freedom Works Radio…
Search Posts
News Release
Institute Cheers Court Decision, Cautiously: Free Speech Protected, but FDA Regulation of Tobacco Unwarranted
WASHINGTON, DC April 25, 1997 — The Competitive Enterprise Institute gave one cheer for today's federal court ruling that overturned FDA's attempt to restrict…
News Release
Institute Calls for USDA to Truly Reinvent Itself in Wake of Strawberry Fiasco
WASHINGTON, DC April 2, 1997– As thousands of public school students prepare to get hepatitis vaccines due to contaminated school lunch strawberry desserts distributed…
News Release
National Poll on Air Bags Shows Need for Change
WASHINGTON, DC March 28, 1997 — By a ratio of nearly 3 to 1, the public favors giving people the choice of purchasing a…
Study
Sudden Impact: The Collision Between The Air Bag Mandate And Ethics
Full Document Available in PDF Air bags…
News Release
New CEI Study: Promising Treatments Delayed by FDA
Charging that outgoing FDA Commissioner David Kessler has left a legacy of increased bureaucracy and deadly overcaution, the Competitive Enterprise Institute will release a new…
News Release
New FDA Bill Offers Hope for the Desperate
The Access to Medical Treatment Act (H.R. 746 ), a bipartisan bill being introduced in the House today, marks a step forward in both medicine…